Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

Loncar China BioPharma ETF CHNA NASDAQ

NASDAQ Global Market • Financial Services • Asset Management • US • USD

SharesGrow Intrinsic Value
N/A
Negative cash flow

Stock Chart & Stats

Market Data
52-Week Range9.76966-22.89
Volume9
Avg Volume (30D)534
Beta (1Y)0.92
IPO Date2018-08-15
Financial Highlights & Ratios
Analyst Forecast
Company Info
CountryUS
ExchangeNASDAQ Global Market
CurrencyUSD
ISINUS26922A3703

Price Chart

Track all markets on TradingView
CHNA
Loncar China BioPharma ETF  ·  NASDAQ Global Market
Financial Services • Asset Management
9.77 52WK RANGE 22.89

People Also View

KURE
KURE
KraneShares MSCI All China Health Care Index ETF
$18.33
+2.34%
 FCA
FCA
First Trust China AlphaDEX Fund
$32.60
-0.70%
 CHIH
CHIH
Global X MSCI China Health Care ETF
$12.39
+0.00%
 CNCR
CNCR
Loncar Cancer Immunotherapy ETF
$9.02
+1.58%
 CHIM
CHIM
Global X MSCI China Materials ETF
$13.30
+0.00%
 VITSX
VITSX
Vanguard Total Stock Market Index Fund Institutional Shares
$166.82
+1.15%
 VTSAX
VTSAX
Vanguard Total Stock Market Index Fund Admiral Shares
$166.79
+1.15%
 VSMPX
VSMPX
Vanguard Total Stock Market Index Fund Institutional Plus Shares
$312.93
+1.15%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message